FMS Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)
NYSE · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Feb 24, 2026
$22.25
· of 52w range
· above low
· to high
$20.0252w low
$27.6452w high
P/E
7.1
EPS
$3.36
Revenue
$19.63B
your badges
52W Range
$20–$28
Analyst Rating
HOLD
Price Target
$24
P/E
7.1
ROE
7.0%
Net Profit Margin
5.0%
Your badge strip is empty — pin a metric anywhere on this page.
FMS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$22.25
P/E
7.1
EPS
$3.36
Revenue
$19.63B
ROE
7.0%
52W Range
$20–$28
FMS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Dec. 4, 2012 | 2-for-1 | Forward |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$19.63B2016-12-31 → 2025-12-31
EPS$3.362016-12-31 → 2025-12-31
Free Cash Flow·2016-12-31 → 2019-12-31
Net margin5.0%2017-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | FMS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | 7.15Y avg ≈9.7 | ≈9.7 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | FMS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin | 9.3%5Y avg ≈8.4% | ≈8.4% | · | · | |
| EBITDA Margin | 16.8%5Y avg ≈16.7% | ≈16.7% | · | · | |
| Pretax Margin | 7.7%5Y avg ≈6.7% | ≈6.7% | · | · | |
| Net Profit Margin | 5.0%5Y avg ≈3.9% | ≈3.9% | · | · | |
| ROA | 3.0%5Y avg ≈2.2% | ≈2.2% | · | · | |
| ROE | 7.0%5Y avg ≈5.5% | ≈5.5% | · | · | |
| ROIC | 10.8%5Y avg ≈8.8% | ≈8.8% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | FMS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 1.35Y avg ≈1.3 | ≈1.3 | · | · | |
| Quick Ratio | 0.15Y avg ≈0.1 | ≈0.1 | · | · | |
| Interest Coverage | 4.95Y avg ≈4.3 | ≈4.3 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | FMS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.65Y avg ≈0.6 | ≈0.6 | · | · | |
| Inventory Turnover | 6.95Y avg ≈6.6 | ≈6.6 | · | · | |
| Revenue / Employee | ≈$183.0K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
Annualized Payout≈$0.87
5Y Div CAGR≈2.9%
Growth Streak≈2
| Ex-date | Amount | Currency | Yield |
|---|---|---|---|
| May 22, 2026 | $0.87 | USD | ≈4.0% |
| May 23, 2025 | $0.82 | USD | ≈2.8% |
| May 17, 2024 | $0.63 | USD | ≈2.9% |
| May 17, 2023 | $0.62 | USD | ≈2.7% |
| May 13, 2022 | $0.71 | USD | ≈2.4% |
| May 24, 2021 | $0.83 | USD | ≈2.1% |
| Aug 28, 2020 | $0.71 | USD | ≈1.7% |
| May 17, 2019 | $0.66 | USD | ≈1.7% |
| May 21, 2018 | $0.63 | USD | ≈1.2% |
| May 11, 2017 | $0.51 | USD | ≈1.1% |
| May 10, 2016 | $0.44 | USD | ≈1.0% |
| May 15, 2015 | $0.44 | USD | ≈1.0% |
| May 13, 2014 | $0.53 | USD | ≈1.6% |
| May 14, 2013 | $0.49 | USD | ≈1.4% |
| May 8, 2012 | $0.46 | USD | ≈1.3% |
| May 10, 2011 | $0.48 | USD | ≈1.3% |
| May 7, 2010 | $0.41 | USD | ≈1.7% |
| May 5, 2009 | $0.37 | USD | ≈2.0% |
| May 16, 2008 | $0.42 | USD | ≈1.5% |
| May 11, 2007 | $0.31 | USD | ≈1.2% |
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
16.5%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | $1.13 | $1.05 | 7.2% | |
| March 31, 2026 | $0.91 | $0.99 | -8.3% | |
| Dec. 31, 2025 | $1.44 | $1.06 | 35.6% | |
| Sept. 30, 2025 | $1.10 | $0.96 | 14.2% | |
| June 30, 2025 | $0.91 | $0.79 | 14.9% | |
| March 31, 2025 | $1.44 | $1.06 | 35.6% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19.63B | $19.34B | $19.45B | $19.40B | $17.62B | $17.86B | $17.48B | $16.55B | $17.78B | $16.57B | $15.45B | $5.27B | |
| Cost of Revenue | $14.60B | $14.58B | $14.53B | $14.50B | $12.85B | $12.32B | $12.08B | $11.39B | $11.77B | $10.95B | $10.28B | $10.84B | |
| Gross Profit | · | · | · | $5.31B | $5.08B | $5.54B | $5.40B | $5.15B | $6.02B | $5.62B | $5.18B | $5.00B | |
| R&D Expense | $158M | $183M | $232M | $229M | $221M | $194M | $168M | $114M | $111M | $147M | $128M | $122M | |
| SG&A Expense | $3.03B | $3.14B | $3.20B | $3.17B | $2.77B | $3.13B | $3.03B | $2.89B | $3.64B | $3.13B | $2.95B | $2.64B | |
| Operating Income | $1.83B | $1.39B | $1.37B | $1.51B | $1.85B | $2.30B | $2.27B | $3.04B | $2.36B | $2.41B | $2.13B | $2.25B | |
| Interest Expense | $375M | $393M | $421M | $359M | $344M | $407M | $486M | $438M | $-365M | $-363M | $458M | $495M | |
| Interest Income | $70M | $72M | $88M | $68M | $73M | $42M | $62M | $147M | $51M | $-63M | $105M | $84M | |
| Pretax Income | $1.51B | $1.06B | $1.03B | $1.22B | $1.57B | $1.94B | $1.84B | $2.74B | $2.00B | $2.05B | $1.78B | $1.84B | |
| Income Tax | $321M | $316M | $301M | $325M | $353M | $501M | $402M | $511M | $443M | $625M | $565M | $584M | |
| Net Income | $978M | $538M | $499M | $673M | $969M | $1.16B | $1.20B | $1.98B | $1.28B | $1.14B | $955M | $1.05B | |
| EPS (Basic) | $3.36 | $1.83 | $1.70 | $2.30 | $3.31 | $3.96 | $3.96 | $6.47 | $4.17 | $3.74 | $3.14 | $3.46 | |
| EPS (Diluted) | $3.36 | $1.83 | $1.70 | $2.30 | $3.31 | $3.96 | $3.96 | $6.45 | $4.16 | $3.73 | $3.13 | $3.45 | |
| Shares (Basic) | 291,190,575 | 293,413,449 | 293,413,449 | 293,246,430 | 292,944,732 | 294,055,525 | 302,691,397 | 306,541,706 | 306,563,400 | 305,748,381,000 | 304,440,184 | 302,339,124 | |
| Shares (Diluted) | · | · | · | · | · | · | · | · | · | 306,257,744 | 304,920,035 | 302,867,896 | |
| EBITDA | $3.29B | $2.93B | $2.98B | $3.23B | $3.44B | $3.89B | $3.82B | $2.31B | $2.36B | $3.41B | $3.04B | $2.95B |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $930M | $837M | $1.08B | $911M | $925M | $747M | $769M | $832M | $620M | $533M | $550M | $634M | |
| Receivables | · | · | · | · | · | · | $3.42B | $3.23B | · | · | $3.29B | $3.20B | |
| Inventory | $2.14B | $2.07B | $2.18B | $2.30B | $2.04B | $1.90B | $1.66B | $1.47B | $1.29B | $1.34B | $1.34B | $1.12B | |
| Prepaid Expense | · | · | · | · | · | · | · | · | · | · | $1.37B | $1.33B | |
| Current Assets | $7.90B | $7.92B | $8.70B | $8.20B | $7.97B | $7.28B | $7.17B | $7.85B | $6.37B | $6.88B | $6.77B | $6.72B | |
| PP&E (Net) | $3.49B | $3.65B | $3.78B | $4.15B | $4.24B | $4.06B | $4.19B | $3.84B | $3.49B | $3.58B | $3.43B | $3.29B | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | $7.41B | $7.04B | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | $3.98B | $3.75B | |
| Goodwill | $13.57B | $15.17B | $14.65B | $15.79B | $14.36B | $12.96B | $14.02B | $12.21B | $12.10B | $12.96B | $13.03B | $13.08B | |
| Intangibles | $1.25B | $1.37B | $1.36B | $1.52B | $1.46B | $1.38B | $1.43B | $681M | $683M | $803M | $830M | $869M | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | $474M | $603M | |
| Total Assets | $31.00B | $33.57B | $33.93B | $35.75B | $34.37B | $31.69B | $32.93B | $26.24B | $24.03B | $25.50B | $25.37B | $25.38B | |
| Accounts Payable | · | · | · | · | · | · | $717M | $641M | $590M | $576M | $628M | $573M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | $2.50B | $2.20B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | $109M | $133M | |
| Current Liabilities | $6.25B | $5.66B | $6.11B | $6.47B | $7.26B | $6.06B | $7.06B | $6.27B | $5.30B | $5.30B | $4.15B | $3.48B | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $624M | $805M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | $466M | $412M | |
| Total Liabilities | $16.72B | $17.80B | $19.10B | $20.30B | $20.39B | $19.36B | $19.71B | $13.34B | $13.20B | $14.45B | $13.84B | $14.53B | |
| Common Stock | · | · | · | · | · | · | · | · | · | · | $387M | $385M | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | $3.47B | $3.55B | |
| Retained Earnings | $12.21B | $11.27B | $10.92B | $10.71B | $10.83B | $10.25B | $9.45B | $8.83B | $7.14B | $6.09B | $7.87B | $7.10B | |
| AOCI | · | · | · | · | · | · | · | · | · | · | $-1.34B | $-1.09B | |
| Stockholders' Equity | $13.31B | $14.58B | $13.62B | $13.99B | $12.70B | $11.22B | $11.96B | $11.76B | $9.82B | $9.98B | $9.89B | $9.44B | |
| Liabilities + Equity | · | · | · | · | · | · | · | · | · | · | $25.37B | $25.38B |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.46B | $1.54B | $1.61B | $1.72B | $1.59B | $1.59B | $1.55B | $725M | $735M | $-702M | $717M | $699M | |
| Stock-based Comp | · | · | · | · | · | · | · | · | · | $26M | $7M | $6M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $-18M | $-47M | $99M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | $118M | $110M | $98M | |
| Other Non-cash | $239M | $313M | $517M | $-225M | $-65M | $1.48B | $-186M | $805M | · | $113M | $254M | $18M | |
| Operating Cash Flow | $2.68B | $2.39B | $2.63B | $2.17B | $2.49B | $4.23B | $2.57B | $2.06B | $2.19B | $1.93B | $1.77B | $1.86B | |
| CapEx | · | · | · | · | · | · | $1.12B | $1.06B | $944M | $-931M | $859M | $932M | |
| Investing Cash Flow | $-723M | $-85M | $-544M | $-735M | $-1.20B | $-1.33B | $-3.29B | $-245M | $-992M | $-1.25B | $-902M | $-2.69B | |
| Dividends Paid | · | · | · | · | · | · | $355M | $325M | $294M | $-244M | $237M | $-318M | |
| Financing Cash Flow | $-1.40B | $-2.57B | $-1.86B | $-1.62B | $-1.02B | $-2.66B | $-467M | $-682M | $-799M | $-520M | $-907M | $805M | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | $198M | $-84M | $-49M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | $599M | $547M | $690M | |
| Free Cash Flow | · | · | · | · | · | · | $1.44B | $3.12B | $1.25B | $1.11B | $1.01B | $930M | |
| Levered FCF | · | · | · | · | · | · | $1.06B | $3.36B | $940M | $796M | $662M | $591M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 27.4% | 28.8% | 31.0% | 30.9% | 31.1% | 33.8% | · | · | 94.9% | |
| Operating Margin | 9.3% | 7.2% | 7.0% | 7.8% | 10.5% | 12.9% | 13.0% | 18.4% | 13.3% | · | · | 42.8% | |
| Net Margin | 5.0% | 2.8% | 2.6% | 3.5% | 5.5% | 6.5% | 6.9% | 12.0% | 7.2% | · | · | 19.9% | |
| Pretax Margin | 7.7% | 5.5% | 5.3% | 6.3% | 8.9% | 10.8% | 10.5% | 16.5% | 11.3% | · | · | 35.0% | |
| EBITDA Margin | 16.8% | 15.1% | 15.3% | 16.7% | 19.5% | 21.8% | 21.9% | 14.0% | 13.3% | · | · | 56.1% | |
| ROA | 3.0% | 1.6% | 1.4% | 1.9% | 2.9% | 3.6% | 4.0% | · | 5.2% | · | · | · | |
| ROE | 7.0% | 3.8% | 3.6% | 5.1% | 8.1% | 10.1% | 10.1% | · | 12.9% | · | · | · | |
| ROIC | 10.8% | 6.7% | 7.1% | 7.9% | 11.3% | 15.2% | 14.8% | · | 18.6% | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | 1.4 | 1.3 | 1.1 | 1.2 | 1.0 | · | 1.2 | · | · | · | |
| Quick Ratio | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.6 | · | 0.1 | · | · | · | |
| Interest Coverage | 4.9 | 3.5 | 3.3 | 4.2 | 5.4 | 5.7 | 4.7 | -10.1 | 5.9 | 5.8 | 4.6 | 4.6 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.6 | · | 0.7 | · | · | · | |
| Inventory Turnover | 6.9 | 6.9 | 6.5 | 6.5 | 6.4 | 6.9 | 7.7 | · | 9.0 | · | · | · | |
| Receivables Turnover | · | · | · | · | · | · | 5.3 | · | · | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | · | · | · | · | · | · | · | · | · | · | · | $17.39 | |
| Cash Flow / Share | · | · | · | · | · | · | · | · | · | $6.99 | $6.43 | $6.15 | |
| Dividend / Share | · | · | · | · | · | · | · | · | · | $0.80 | $0.78 | $0.77 | |
| EPS (TTM) | $3.36 | $1.83 | $1.70 | $2.30 | $3.31 | $3.96 | $3.96 | $6.45 | $4.16 | $3.73 | $3.13 | $3.45 |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $19.63B | $19.34B | $19.45B | $19.40B | $17.62B | $17.86B | $17.48B | $16.55B | $17.78B | $16.57B | $15.45B | $5.27B | |
| Net Income TTM | $978M | $538M | $499M | $673M | $969M | $1.16B | $1.20B | $1.98B | $1.28B | $1.14B | $955M | $1.05B | |
| P/E | 7.1 | 12.4 | 12.3 | 7.1 | 9.8 | 10.5 | 9.3 | 5.0 | 12.6 | 11.3 | 13.4 | 10.8 | |
| Earnings Yield | 14.1% | 8.1% | 8.2% | 14.1% | 10.2% | 9.5% | 10.8% | 19.9% | 7.9% | 8.8% | 7.5% | 9.3% | |
| Payout Ratio | · | · | · | · | · | · | 29.6% | -16.4% | 23.0% | -22.3% | -25.6% | 30.4% | |
| Annual Payout | · | · | · | · | · | · | $355M | $325M | $294M | $-244M | $237M | $-318M |
Balance Sheet
| Metric | Trend | Q4 2018 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2011 | Q4 2010 | Q4 2008 | Q4 2007 | Q4 2006 | Q4 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $832M | $747M | $550M | $634M | · | · | · | · | · | · | |
| Receivables | · | $3.52B | $3.29B | $3.20B | · | · | · | · | · | · | |
| Inventory | $1.47B | $1.41B | $1.34B | $1.12B | · | · | · | · | · | · | |
| Prepaid Expense | · | $1.41B | $1.37B | $1.33B | · | · | · | · | · | · | |
| Current Assets | $7.85B | $7.31B | $6.98B | $6.72B | · | · | · | · | · | · | |
| PP&E (Net) | $3.84B | $3.77B | $3.43B | $3.29B | · | · | · | · | · | · | |
| PP&E (Gross) | · | $8.16B | $7.41B | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | $4.39B | $3.98B | $-3.75B | · | · | · | · | · | · | |
| Goodwill | $12.21B | $13.67B | $13.03B | $13.08B | · | · | · | · | · | · | |
| Intangibles | $681M | $847M | $830M | $869M | · | · | · | · | · | · | |
| Other Non-current Assets | · | $451M | $474M | $663M | · | · | · | · | · | · | |
| Total Assets | $26.24B | $26.93B | $25.53B | $25.45B | · | · | · | · | · | · | |
| Accounts Payable | $641M | $607M | $628M | $573M | · | · | · | · | · | · | |
| Accrued Liabilities | · | $2.65B | $2.50B | $2.20B | · | · | · | · | · | · | |
| Short-term Debt | · | $602M | $109M | $133M | · | · | · | · | · | · | |
| Current Liabilities | $6.27B | $5.04B | $4.19B | $3.48B | · | · | · | · | · | · | |
| Deferred Tax | · | $672M | $756M | $805M | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | $659M | $466M | $412M | · | · | · | · | · | · | |
| Total Liabilities | $13.34B | $14.24B | $14.01B | $14.59B | · | · | · | · | · | · | |
| Common Stock | · | $380M | $387M | $385M | · | · | · | · | · | · | |
| Paid-in Capital | · | $2.98B | $3.47B | $3.55B | · | · | · | · | · | · | |
| Retained Earnings | $8.83B | $8.84B | $7.87B | $7.10B | · | · | · | · | · | · | |
| AOCI | · | $-1.32B | $-1.34B | $-1.09B | · | · | · | · | · | · | |
| Stockholders' Equity | $11.76B | $10.81B | $9.89B | $9.44B | · | · | · | · | · | · | |
| Liabilities + Equity | · | $26.93B | $25.53B | $25.45B | · | · | · | · | · | · | |
| Shares Outstanding | · | 306,221,840 | 305,314,120 | 301,446,779 | · | · | · | · | · | · |
Per Share
| Metric | Trend | Q4 2018 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2011 | Q4 2010 | Q4 2008 | Q4 2007 | Q4 2006 | Q4 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS (TTM) | $6.45 | · | · | · | $3.51 | $3.24 | $2.74 | $2.42 | · | · |
Valuation (TTM)
| Metric | Trend | Q4 2018 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2011 | Q4 2010 | Q4 2008 | Q4 2007 | Q4 2006 | Q4 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $16.55B | · | · | · | · | · | · | · | · | · | |
| Net Income TTM | $1.98B | · | · | · | $1.07B | $979M | $818M | $717M | · | · | |
| P/E | 5.0 | · | · | · | 9.7 | 8.9 | 8.6 | 10.9 | · | · | |
| Earnings Yield | 19.9% | · | · | · | 10.3% | 11.2% | 11.6% | 9.2% | · | · | |
| Annual Payout | $325M | · | · | · | $281M | $232M | $252M | $188M | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $19.63B | $19.34B | $19.45B | $19.40B | $17.62B |
| Gross Margin % | · | · | · | 27.4% | 28.8% |
| Operating Margin % | 9.3% | 7.2% | 7.0% | 7.8% | 10.5% |
| Net Income | $978M | $538M | $499M | $673M | $969M |
| Diluted EPS | $3.36 | $1.83 | $1.70 | $2.30 | $3.31 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | 1.4 | 1.3 | 1.1 |
| Quick Ratio | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 252 filers · $943.5M total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
252
Value held
$943.5M
New positions
47
Exited positions
27
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 47 (0 vs prior Q) | 27 (-7 vs prior Q) | 101 (+12 vs prior Q) | 44 (-1 vs prior Q) | +363K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| PZENA INVESTMENT MANAGEMENT LLC | $338,970,952 | 14,992,081 | 35.93% | Shares |
| MORGAN STANLEY | $98,302,636 | 4,347,748 | 10.42% | Shares |
| Dodge & Cox | $86,526,435 | 3,826,910 | 9.17% | Shares |
| FIDUCIARY MANAGEMENT INC /WI/ | $66,424,314 | 2,937,829 | 7.04% | Shares |
| BRANDES INVESTMENT PARTNERS, LP | $43,323,176 | 1,916,090 | 4.59% | Shares |
| MILLENNIUM MANAGEMENT LLC | $35,538,511 | 1,571,805 | 3.77% | Shares |
| TODD ASSET MANAGEMENT LLC | $29,514,940 | 1,305,386 | 3.13% | Shares |
| GOLDMAN SACHS GROUP INC | $20,318,888 | 898,668 | 2.15% | Shares |
| BlackRock, Inc. | $19,451,429 | 860,302 | 2.06% | Shares |
| Quantinno Capital Management LP | $11,937,327 | 527,966 | 1.27% | Shares |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $10,526,922 | 465,587 | 1.12% | Shares |
| ENVESTNET ASSET MANAGEMENT INC | $9,692,471 | 428,696 | 1.03% | Shares |
| NORTHERN TRUST CORP | $8,703,946 | 384,960 | 0.92% | Shares |
| WELLS FARGO & COMPANY/MN | $8,622,583 | 381,361 | 0.91% | Shares |
| RAYMOND JAMES FINANCIAL INC | $8,247,454 | 364,770 | 0.87% | Shares |
| Moran Wealth Management, LLC | $8,188,845 | 362,178 | 0.87% | Shares |
| Creative Planning | $6,722,694 | 297,333 | 0.71% | Shares |
| ROYAL BANK OF CANADA | $5,942,000 | 262,797 | 0.63% | Shares |
| FMR LLC | $5,554,864 | 245,682 | 0.59% | Shares |
| ABC ARBITRAGE SA | $5,420,770 | 239,751 | 0.57% | Shares |
| JPMORGAN CHASE & CO | $5,043,147 | 222,165 | 0.53% | Shares |
| UBS Group AG | $4,968,502 | 219,748 | 0.53% | Shares |
| D. E. Shaw & Co., Inc. | $4,764,990 | 210,747 | 0.51% | Shares |
| ASSETMARK, INC | $4,127,878 | 182,569 | 0.44% | Shares |
| Trexquant Investment LP | $4,067,245 | 179,887 | 0.43% | Shares |
| Cinctive Capital Management LP | $3,776,232 | 167,016 | 0.40% | Shares |
| NIA IMPACT ADVISORS, LLC | $3,092,356 | 136,769 | 0.33% | Shares |
| RITHOLTZ WEALTH MANAGEMENT | $2,903,193 | 128,403 | 0.31% | Shares |
| JANE STREET GROUP, LLC | $2,303,462 | 101,878 | 0.24% | Shares |
| STIFEL FINANCIAL CORP | $2,152,041 | 95,180 | 0.23% | Shares |
| Cubist Systematic Strategies, LLC | $2,094,762 | 79,558 | 0.22% | Shares |
| QRG CAPITAL MANAGEMENT, INC. | $2,018,326 | 89,267 | 0.21% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $2,015,048 | 89,122 | 0.21% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $1,915,142 | 84,703 | 0.20% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,891,191 | 83,644 | 0.20% | Shares |
| NATIONAL BANK OF CANADA /FI/ | $1,855,101 | 82,048 | 0.20% | Shares |
| SEARLE & CO. | $1,825,192 | 80,725 | 0.19% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,770,363 | 78,300 | 0.19% | Put option |
| Point72 Asset Management, L.P. | $1,737,104 | 76,829 | 0.18% | Shares |
| DIVERSIFIED MANAGEMENT INC | $1,647,940 | 73,047 | 0.17% | Shares |
| SEI INVESTMENTS CO | $1,605,420 | 71,001 | 0.17% | Shares |
| Pathstone Holdings, LLC | $1,574,508 | 69,638 | 0.17% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1,512,541 | 66,897 | 0.16% | Shares |
| XTX Topco Ltd | $1,493,911 | 66,073 | 0.16% | Shares |
| BANK OF MONTREAL /CAN/ | $1,410,140 | 62,368 | 0.15% | Shares |
| BANK OF AMERICA CORP /DE/ | $1,345,691 | 59,517 | 0.14% | Shares |
| BAROMETER CAPITAL MANAGEMENT INC. | $1,315,902 | 58,200 | 0.14% | Shares |
| Crossmark Global Holdings, Inc. | $1,308,961 | 57,893 | 0.14% | Shares |
| TWO SIGMA INVESTMENTS, LP | $1,303,987 | 57,673 | 0.14% | Shares |
| MML INVESTORS SERVICES, LLC | $1,297,015 | 57,365 | 0.14% | Shares |
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Fresenius SE & Co. KGaA ×10 filings | Aug. 24, 2026 | 25.60% | Amendment | Passive investment | SEC |
| Fresenius Medical Care Holdings, Inc., Fresenius Medical Care AG | Jan. 9, 2026 | 9.50% | Amendment | · | SEC |
| Fresenius Medical Care AG | Oct. 16, 2025 | 9.90% | Amendment | · | SEC |
| Fresenius SE | July 29, 2008 | · | Initial filing | M&A / sale | SEC |
| Undisclosed reporting person | April 5, 2006 | · | Initial filing | Board campaign | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 4 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
FMS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 29 analysts
HOLD
Median target
$23.98
+7.8%
3 10.3%
Strong Buy
3 10.3%
Buy
11 37.9%
Hold
10 34.5%
Sell
2 6.9%
Strong Sell
12-Month Price Target
7 analysts · 2026-09-30Mean target $23.76 +6.8%
Now
Current price $22.25
Low$17.05
Mean$23.76
High$37.51
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Feb 24, 2026